Chargement en cours...
Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma
Autologous stem cell transplantation (ASCT) can be curative for patients with relapsed/refractory Hodgkin lymphoma (HL). Based on studies suggesting that anti-PD-1 monoclonal antibodies (mAbs) can sensitize patients to subsequent chemotherapy, we hypothesized that anti-PD-1 therapy before ASCT would...
Enregistré dans:
| Publié dans: | Blood Adv |
|---|---|
| Auteurs principaux: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society of Hematology
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7993097/ https://ncbi.nlm.nih.gov/pubmed/33710337 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020003556 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|